Vulnerability Report

CVE-2022-42119

Title: Liferay Liferay Portal Cross-Site Scripting (XSS)

XSS

Proof Of Concept

No public PoC currently indexed for CVE-2022-42119.

CWE Category CWE-79
Published Date Nov 15, 2022
Modified Date Jul 09, 2026
Exploit Status Not Found
Score 5.4 CVSS v3.1
Exploit Probability (EPSS)
0.39%

Vulnerability Summary

CVE-2022-42119: Certain Liferay products are vulnerable to Cross Site Scripting (XSS) via the Commerce module. This affects Liferay Portal 7.3.5 through 7.4.2 and Liferay DXP 7.3 before update 8.

Impacted Vendors

L
liferay 2

Reference Links

http://liferay.com https://issues.liferay.com/browse/LPE-17632 https://portal.liferay.dev/learn/security/known-vulnerabilities/-/asset_publisher/HbL5mxmVrnXW/content/cve-2022-42119 http://liferay.com https://issues.liferay.com/browse/LPE-17632 https://portal.liferay.dev/learn/security/known-vulnerabilities/-/asset_publisher/HbL5mxmVrnXW/content/cve-2022-42119
CVSS v3.1
Source Entity [email protected]
Severity MEDIUM
5.4
Attack Vector
NETWORK
Complexity
LOW
Privileges
N/A
Interaction
REQUIRED
Confidentiality
N/A
Integrity
N/A
Availability
N/A
Scope
CHANGED
RAW VECTOR CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
CVSS v3.1
Source Entity 134c704f-9b21-4f2e-91b3-4a467353bcc0
Severity MEDIUM
5.4
Attack Vector
NETWORK
Complexity
LOW
Privileges
N/A
Interaction
REQUIRED
Confidentiality
N/A
Integrity
N/A
Availability
N/A
Scope
CHANGED
RAW VECTOR CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Associated Attack Patterns (CAPEC)

Total: Patterns

CVE-2022-42119 Exploits & PoCs (Proof Of Concept)

No public PoCs found in our database for this CVE.

MODIFIED

Vulnerability data updated via NVD.

MODIFIED

Vulnerability data updated via NVD.

MODIFIED

Vulnerability data or affected products updated.

PUBLISHED

Vulnerability first announced in NVD.

Attack Vector Matrix

Access Vector NETWORK
Complexity LOW
Privileges N/A
Interaction REQUIRED
CVSS Vector String CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Affected Stack

No specific products linked.